Product Information
POTASSIUM CITRATE ER 5 MEQ TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.1348 per EA under NDC 00591268201. Its NADAC has been published 417 times since Jul 4, 2018.
Strength
5 meq/1
Manufacturer
Actavis Pharma, Inc.NDC
00591268201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
POTASSIUM CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209758On Market Since
5/30/2018
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has been published 417 times since Jul 4, 2018, and over the history we have for it it has declined 80.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1348 per EA |
|---|---|
| All-time high | $0.8278 (Sep 12, 2018) |
| All-time low | $0.1064 (May 22, 2024) |
| 52-week high | $0.1499 |
| 52-week low | $0.1217 |
| Median price | $0.4459 |
| Average price | $0.3944 |
| Largest weekly change | +79.1% (Jan 18, 2023) |
| Weeks tracked | 417 |
| Tracking since | Jul 4, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of POTASSIUM CITRATE ER 5 MEQ TAB?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 5 MEQ TAB, manufactured by Actavis Pharma, Inc., is $0.1348 per EA (NDC 00591268201), effective Jun 24, 2026.
How has the price of POTASSIUM CITRATE ER 5 MEQ TAB changed over time?
Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has declined 80.5%. It has been tracked across 417 weekly CMS publications since Jul 4, 2018.
What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 5 MEQ TAB?
Since Jul 4, 2018, the NADAC for POTASSIUM CITRATE ER 5 MEQ TAB has ranged from a low of $0.1064 (May 22, 2024) to a high of $0.8278 (Sep 12, 2018), with a median of $0.4459 per EA.
Are there cheaper alternatives to POTASSIUM CITRATE ER 5 MEQ TAB?
2 NADAC-published products share the same active ingredient, strength, and dosage form as POTASSIUM CITRATE ER 5 MEQ TAB, but none are currently priced below it.
Who manufactures POTASSIUM CITRATE ER 5 MEQ TAB?
POTASSIUM CITRATE ER 5 MEQ TAB (NDC 00591268201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification